Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Hospital Sant Joan De Deu currently has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners, which indicates the current portfolio involves multiple individual perspectives. Furthermore, the data shows that 2 distinct art units are involved in these proceedings. This variety indicates that the company's patent applications cover different technical subjects within the pharmaceutical field, requiring a prosecution strategy that can adapt to different USPTO departments.
The busiest examiner, DABKOWSKI, ERINNE R, is responsible for 1 pending action. Because there are 2 pending office actions in total, the workload is distributed across the 2 distinct examiners. This distribution means that the company's outcomes are not determined by the discretion of 1 examiner alone. For a practitioner, the presence of 2 distinct art units means that responses must be tailored to the specific examination standards of each unit. This diversity in the portfolio requires coordination to maintain messaging across the 2 distinct examiners.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DABKOWSKI, ERINNE R | 1 | 55.8% | +68.7% |
| VIVLEMORE, TRACY ANN | 1 | 73.0% | +6.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18028515 | PEPTIDIC CONJUGATES OF SN38 USEFUL IN THE TREATMENT OF CANCER | DABKOWSKI, ERINNE R | — |
| Art Unit | Apps |
|---|---|
| 1654 | 1 |
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18028515 | PEPTIDIC CONJUGATES OF SN38 USEFUL IN THE TREATMENT OF CANCER | DABKOWSKI, ERINNE R | 1654 | §112DP | Non-Final OA | — | Pending | Mar 24, 2023 |
| 16461680 | USE OF VIRAL VECTORS IN THE TREATMENT OF RETINOBLASTOMA | VIVLEMORE, TRACY ANN | 1638 | §103 | Final Rejection | 86d overdue | Pending | May 16, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHospital Sant Joan De Deu has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Erinne R Dabkowski has the most, with 1 of Hospital Sant Joan De Deu's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
